Socket Mobile, Inc. (NASDAQ: SCKT) 215% HIGHER; announced the arrival of the DuraSled, the first enterprise-grade barcode scanner for the iPhone 12, iPhone 12 Pro, iPhone 12 Pro Max and iPhone 12 Mini. With the sleek, high-performance DuraSled, users of all Apple iPhone 12 series devices can access professional-grade scanning solutions.

500.com Limited (NYSE: WBAI) 65.6% HIGHER; entered into a share exchange agreement (the "Share Exchange Agreement") with Blockchain Alliance Technologies Holding Company ("Blockchain Alliance"), a Cayman Islands company and a "Non-U.S. Person" as defined in Regulation S of the Securities Act of 1933, as amended, pursuant to which to Company has agreed to issue an aggregate of 44,353,435 Class A ordinary shares of par value US$0.00005 per share of the Company (the "Class A Ordinary Shares") to Blockchain Alliance at the first closing, which shares represent approximately 10% of the Company's outstanding shares as of January 31, 2021, in exchange for the entire outstanding share capital of Blockchain Alliance Technologies Limited held by Blockchain Alliance after the reorganization. The first closing of the transactions contemplated by the Share Exchange Agreement (the "Transactions") is subject to certain closing conditions, which include, among others, the transfer to the Company of the entire mining pool business of Bitdeer Technologies Holding Company ("BitDeer") operated under BTC.com, including the domain name BTC.com and the cryptocurrency wallet of BTC.com (collectively, the "BTC.com Pool Businesses"). The first closing is expected to occur on or before April 15, 2021.

Sesen Bio (Nasdaq: SESN) 28.2% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) accepted for filing the Companys Biologics License Application (BLA) for Vicineum for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), and granted the application Priority Review. In addition, the FDA stated that it is not currently planning to hold an advisory committee meeting to discuss the BLA for Vicineum.

bluebird bio, Inc. (Nasdaq: BLUE) 26.3% LOWER; announced today that the company has placed its Phase 1/2 (HGB-206) and Phase 3 (HGB-210) studies of LentiGlobin gene therapy for sickle cell disease (SCD) (bb1111) on a temporary suspension due to a reported Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemia (AML).

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) 25.9% LOWER; announced the pricing of its underwritten public offering of 44,200,000 shares of its common stock at a public offering price of $2.00 per share, for gross proceeds of $88.4 million before deducting underwriting discounts, commissions and other offering expenses. All of the shares of common stock are being offered by the Company.

Sino-Global Shipping America, Ltd. (NASDAQ: SINO) 24.9% HIGHER; signed a Letter of Intent ("LOI") to acquire 51% of Inner Mongolia Nine-Chain Intelligent Big Data Park Service Co., Ltd. ("Nine-Chain Intelligent").

G1 Therapeutics, Inc. (Nasdaq: GTHX) 24.5% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved COSELA (trilaciclib) for injection to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer (ES-SCLC). It is the first and only therapy designed to help protect bone marrow (myeloprotection) when administered prior to treatment with chemotherapy. COSELA is expected to be commercially available through G1s specialty distributor partner network in early March.

Peridot Acquisition Corp. (NYSE: PDAC) 12.6% HIGHER; Li-Cycle Corp. , a commercial leader in lithium-ion battery resource recovery, and Peridot Acquisition Corp. (NYSE: PDAC), a publicly-traded special purpose acquisition company sponsored by Carnelian Energy Capital, announced their entry today into a definitive business combination agreement that will result in Li-Cycle becoming a public company. Upon closing of the transaction, the combined company will be renamed Li-Cycle Holdings Corp. and will be listed on the New York Stock Exchange under the new ticker symbol “LICY.” The combined company will be led by Ajay Kochhar, Co-Founder, President and Chief Executive Officer of Li-Cycle, and Tim Johnston, Co-Founder and Executive Chairman.

Bio-Path Holdings, Inc., (Nasdaq: BPTH) 9.4% LOWER; announced the pricing of its previously announced public offering for the offering of 1,710,600 shares of common stock at a price to the public of $7.60 per share, for aggregate gross proceeds to the Company of approximately $13.0 million, before deducting the fees and estimated offering expenses payable by the Company. The offering is expected to close on or about February 18, 2021, subject to customary closing conditions.

Nano Dimension Ltd. (NASDAQ: NNDM) 8% LOWER; entered into definitive agreements with investors for the sale of 39,100,000 of the Company’s American Depositary Shares (“ADSs”) at a price of $12.80 per ADS pursuant to a registered direct offering. The gross proceeds of the offering will be approximately $500 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds for working capital and for other general corporate purposes, and pursuing strategic opportunities, including possible business combination transactions. The closing of the registered direct offering is expected to take place on or about February 18, 2021, subject to the satisfaction of customary closing conditions.